TREM2 and Insulin resistance: In the DioGenes (44) and METSIM (45) studies of overweight or obese participants, SAT expression of components of the TREM2-TYROBP network was found to correlate with clinical measures of insulin resistance (Supplemental Tables 12 and 13).